The stock's rise snapped a four-day losing streak.

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

The "Microfluidic Devices Market (By Device Type, Material, Application, Industry and Region), Company Profiles, Trends, SWOT Analysis, and Recent Developments - Global Forecast (2025 - 2032)" report ...

President Donald Trump’s nominee for the top policy job at the Pentagon acknowledged during his confirmation hearing on Tuesday that Russia invaded Ukraine and poses a significant military threat to ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

enabling better and timelier diagnostics for customers and significant benefits for the health care system.11 Illumina’s customer base has evolved from predominantly research focused ...

Health care is the discipline concerned with the provision and delivery of health services to a patient population by personnel in professional and allied health occupations. Generalist AI systems ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...